MP71-02 A COMPARISON OF MORBIDITY ASSOCIATED WITH TRANS-URETHRAL RESECTION OF THE PROSTATE (TURP) AND TRANSVESICAL PROSTATECTOMY (TVP) FOR PATIENTS WITH PROSTATE VOLUME 80 – 110G

Abstract

You have accessJournal of UrologyBenign Prostatic Hyperplasia: Surgical Therapy & New Technology II1 Apr 2014MP71-02 A COMPARISON OF MORBIDITY ASSOCIATED WITH TRANS-URETHRAL RESECTION OF THE PROSTATE (TURP) AND TRANSVESICAL PROSTATECTOMY (TVP) FOR PATIENTS WITH PROSTATE VOLUME 80 – 110G Elcio Nakano, Eduardo M. Yoshinaga, Giovanni Marchini, Paulo Cordeiro, Fabio Tanno, Miguel Srougi, and Alberto Antunes Elcio NakanoElcio Nakano More articles by this author , Eduardo M. YoshinagaEduardo M. Yoshinaga More articles by this author , Giovanni MarchiniGiovanni Marchini More articles by this author , Paulo CordeiroPaulo Cordeiro More articles by this author , Fabio TannoFabio Tanno More articles by this author , Miguel SrougiMiguel Srougi More articles by this author , and Alberto AntunesAlberto Antunes More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2014.02.2161AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES To compare retrospectively the morbidity of surgical management of benign prostatic hyperplasia (BPH) with monopolar TURP and TVP when treating patients with large prostates METHODS We performed a retrospective analysis on our prospectively collected database searching for patients who underwent surgical treatment of symptomatic BPH between Jan/08 and Jun/13. Inclusion criteria: patients candidates to surgical management of BPH with prostate volume between 80 and 110g, which were suitable to both open and endoscopic approach (chosen according to surgeon preference). Analyzed data included patient age, comorbidities (ASA score; Charlson index – severe if ≥2), serum prostate specific antigen (PSA), prostate volume (transabdominal ultrasound), use of Foley catheter, and surgical complications (Clavien score). Student T test and Chi-Square/Fisher Exact test were used. Significance was set at p≤0.05. RESULTS 1460 patients underwent surgical treatment of BPH: 296 TVP, 1064 TURP. Of those, 87 (29.4%) TVP and 104 (9.8%) TURP met our prostate volume inclusion criteria and were considered for further analysis. Groups were similar in regards to use of Foley, PSA, PSA density, ASA and Charlson scores (table 1). Patients in the TVP group were older (p<0.001) and had larger prostates (p<0.001). TVP provided a larger resected prostate volume when compared to TURP (72.2 vs. 40.8%, respectively; p<0.001), with a higher decrease in PSA levels (p<0.001). The incidence of severe complications (Clavien≥3) was similar between cohorts (p=0.18). In a subanalysis of patients with more comorbidities (Charlson ≥2 and ASA ≥2), severe complications occurred more in the TVP group (p≤0.05) (table 2). CONCLUSIONS TURP and TVP techniques for patients with prostate volume between 80 and 110g have a similar rate of complications. Patients with more comorbidities have a higher index of complications when treated with TVP. © 2014FiguresReferencesRelatedDetails Volume 191Issue 4SApril 2014Page: e789 Advertisement Copyright & Permissions© 2014MetricsAuthor Information Elcio Nakano More articles by this author Eduardo M. Yoshinaga More articles by this author Giovanni Marchini More articles by this author Paulo Cordeiro More articles by this author Fabio Tanno More articles by this author Miguel Srougi More articles by this author Alberto Antunes More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...